A citation-based method for searching scientific literature

Paul C D Bank, Jesse J Swen, Henk-Jan Guchelaar. Adv Pharmacol 2018
Times Cited: 14







List of co-cited articles
98 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
262
50

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
138
42

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
271
35

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
169
35


Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
371
35

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
956
28

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
M Verbelen, M E Weale, C M Lewis. Pharmacogenomics J 2017
97
28

A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Paul C D Bank, Jesse J Swen, Rowena D Schaap, Daniëlle B Klootwijk, Renée Baak-Pablo, Henk-Jan Guchelaar. Eur J Hum Genet 2019
21
28


HLA-B*5701 screening for hypersensitivity to abacavir.
Simon Mallal, Elizabeth Phillips, Giampiero Carosi, Jean-Michel Molina, Cassy Workman, Janez Tomazic, Eva Jägel-Guedes, Sorin Rugina, Oleg Kozyrev, Juan Flores Cid,[...]. N Engl J Med 2008
21

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
P C D Bank, K E Caudle, J J Swen, R S Gammal, M Whirl-Carrillo, T E Klein, M V Relling, H-J Guchelaar. Clin Pharmacol Ther 2018
106
21

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
593
21

Pharmacogenetics: from bench to byte.
J J Swen, I Wilting, A L de Goede, L Grandia, H Mulder, D J Touw, A de Boer, J M H Conemans, T C G Egberts, O H Klungel,[...]. Clin Pharmacol Ther 2008
154
21

Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
125
21

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
James M Hoffman, Cyrine E Haidar, Mark R Wilkinson, Kristine R Crews, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Ching-Hon Pui, Ulrike M Reiss, Aditya H Gaur,[...]. Am J Med Genet C Semin Med Genet 2014
153
21

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.
J S Schildcrout, J C Denny, E Bowton, W Gregg, J M Pulley, M A Basford, J D Cowan, H Xu, A H Ramirez, D C Crawford,[...]. Clin Pharmacol Ther 2012
125
21

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Volker M Lauschke, Lili Milani, Magnus Ingelman-Sundberg. AAPS J 2017
64
21

Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges.
M J Arwood, S Chumnumwat, L H Cavallari, E A Nutescu, J D Duarte. Clin Transl Sci 2016
43
21

Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
Cathelijne H van der Wouden, Mandy H van Rhenen, Wafa O M Jama, Magnus Ingelman-Sundberg, Volker M Lauschke, Lidija Konta, Matthias Schwab, Jesse J Swen, Henk-Jan Guchelaar. Clin Pharmacol Ther 2019
37
21


Translating pharmacogenomics: challenges on the road to the clinic.
Jesse J Swen, Tom W Huizinga, Hans Gelderblom, Elisabeth G E de Vries, Willem J J Assendelft, Julia Kirchheiner, Henk-Jan Guchelaar. PLoS Med 2007
116
21

Assessment of the pharmacogenomics educational needs of pharmacists.
Kristen B McCullough, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson. Am J Pharm Educ 2011
120
21

Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.
Dan M Roden, Sara L Van Driest, Jonathan D Mosley, Quinn S Wells, Jamie R Robinson, Joshua C Denny, Josh F Peterson. Clin Pharmacol Ther 2018
47
21

Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
Susanne B Haga, Nancy M Allen LaPointe, Alex Cho, Shelby D Reed, Rachel Mills, Jivan Moaddeb, Geoffrey S Ginsburg. Pharmacogenomics 2014
23
21

Genetic variation in the human cytochrome P450 supergene family.
Kohei Fujikura, Magnus Ingelman-Sundberg, Volker M Lauschke. Pharmacogenet Genomics 2015
86
14

A method and server for predicting damaging missense mutations.
Ivan A Adzhubei, Steffen Schmidt, Leonid Peshkin, Vasily E Ramensky, Anna Gerasimova, Peer Bork, Alexey S Kondrashov, Shamil R Sunyaev. Nat Methods 2010
14

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
226
14

A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Talitha I Verhoef, Georgia Ragia, Anthonius de Boer, Rita Barallon, Genovefa Kolovou, Vana Kolovou, Stavros Konstantinides, Saskia Le Cessie, Efstratios Maltezos, Felix J M van der Meer,[...]. N Engl J Med 2013
165
14

A randomized trial of genotype-guided dosing of warfarin.
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, Andrea L Jorgensen, Cheng Hock Toh, Toby Nicholson, Patrick Kesteven, Christina Christersson, Bengt Wahlström, Christina Stafberg,[...]. N Engl J Med 2013
547
14

A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Stephen E Kimmel, Benjamin French, Scott E Kasner, Julie A Johnson, Jeffrey L Anderson, Brian F Gage, Yves D Rosenberg, Charles S Eby, Rosemary A Madigan, Robert B McBane,[...]. N Engl J Med 2013
505
14

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Marieke J H Coenen, Dirk J de Jong, Corine J van Marrewijk, Luc J J Derijks, Sita H Vermeulen, Dennis R Wong, Olaf H Klungel, Andre L M Verbeek, Piet M Hooymans, Wilbert H M Peters,[...]. Gastroenterology 2015
110
14

Integrating rare genetic variants into pharmacogenetic drug response predictions.
Magnus Ingelman-Sundberg, Souren Mkrtchian, Yitian Zhou, Volker M Lauschke. Hum Genomics 2018
78
14

Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Alan R Shuldiner, Kathleen Palmer, Ruth E Pakyz, Tameka D Alestock, Kristin A Maloney, Courtney O'Neill, Shaun Bhatty, Jamie Schub, Casey Lynnette Overby, Richard B Horenstein,[...]. Am J Med Genet C Semin Med Genet 2014
63
14

Pharmacogenomically actionable medications in a safety net health care system.
Janet S Carpenter, Marc B Rosenman, Mitchell R Knisely, Brian S Decker, Kenneth D Levy, David A Flockhart. SAGE Open Med 2016
17
14

Pharmacogenomics and individualized medicine: translating science into practice.
K R Crews, J K Hicks, C-H Pui, M V Relling, W E Evans. Clin Pharmacol Ther 2012
139
14


The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin Pharmacol Ther 2017
81
14

Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study.
Iris Cohn, Tara A Paton, Christian R Marshall, Raveen Basran, Dimitri J Stavropoulos, Peter N Ray, Nasim Monfared, Robin Z Hayeems, M Stephen Meyn, Sarah Bowdin,[...]. NPJ Genom Med 2017
18
14

Cost effectiveness of pharmacogenomics: a critical and systematic review.
William B Wong, Josh J Carlson, Rahber Thariani, David L Veenstra. Pharmacoeconomics 2010
76
14

Positive perception of pharmacogenetic testing for psychotropic medications.
Matthew B Lanktree, Gwyneth Zai, Laura E Vanderbeek, Daniel E Giuffra, David S Smithson, Lucas B Kipp, Timothy R Dalseg, Mark Speechley, James L Kennedy. Hum Psychopharmacol 2014
13
15

Pharmacogenomics in a community pharmacy: ACT now.
Lisa Padgett, Shanna O'Connor, Mary Roederer, Howard McLeod, Stefanie Ferreri. J Am Pharm Assoc (2003) 2011
27
14

Pharmacogenomics: bench to bedside.
Richard Weinshilboum, Liewei Wang. Nat Rev Drug Discov 2004
175
14

Personalized medicines - are pharmacists ready for the challenge?
Mary Jayne Kennedy. Integr Pharm Res Pract 2018
11
18

The path to personalized medicine.
Margaret A Hamburg, Francis S Collins. N Engl J Med 2010
962
14

Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.
M A Martin, T E Klein, B J Dong, M Pirmohamed, D W Haas, D L Kroetz. Clin Pharmacol Ther 2012
118
14

Complexities of CYP2D6 gene analysis and interpretation.
Andrea Gaedigk. Int Rev Psychiatry 2013
134
14

Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.
Katrina M Romagnoli, Richard D Boyce, Philip E Empey, Solomon Adams, Harry Hochheiser. Int J Med Inform 2016
18
14

Pharmacogenetic Information in Clinical Guidelines: The European Perspective.
Jesse J Swen, Marga Nijenhuis, Mandy van Rhenen, Nienke J de Boer-Veger, Anne-Marie Buunk, Elisa J F Houwink, Hans Mulder, Gerard A Rongen, Ron H N van Schaik, Jan van der Weide,[...]. Clin Pharmacol Ther 2018
38
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.